Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of British Columbia
$105,000.00
Effect of perturbed c-MYC expression on chronic myeloid leukemia disease progression.
FY 2015-16
Summary
Normal blood cell production is maintained by rare immature cells that reside in the bone marrow. These are the cells that become transformed to give rise to leukemia which is a cancer of the blood. Many forms of leukemia are still not effectively treatable and are therefore fatal within a few years. Unfortunately we know very little about how these leukemias develop and why they are so resistant to therapy. In addition, methods that produce mouse leukemias do not generate diseases that closely resemble human leukemias. Therefore models that would allow to study the initiation and progression of leukemia directly in human cells are needed. The objective of my project is to create and study such a model of a human leukemia by introducing a mutant gene into normal human cells and cells that are pre-leukemic. In my preliminary experiments, I have already discovered that this can work and the altered cells produce an aggressive human leukemia when they are transplanted into mice that lack an immune system. I now propose to investigate the molecular changes that cause this generation of a leukemia in the targeted cells. My results should create a foundation for the future development of definitive curative strategies and also broaden our understanding of the behaviour of other cancers where the same mutant gene is active.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
347959
Name
Bulaeva Elizaveta
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Effect of perturbed c-MYC expression on chronic myeloid leukemia disease progression.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Acute Leukemia; C-Myc; Cancer Stem Cell; Chronic Myeloid Leukemia; Dna Barcoding Technology; Flow And Mass Cytometry; Human Hematopoietic Stem Cell; Lentiviral Transduction; Leukemia Modelling; Oncogene
Abstract
Normal blood cell production is maintained by rare immature cells that reside in the bone marrow. These are the cells that become transformed to give rise to leukemia which is a cancer of the blood. Many forms of leukemia are still not effectively treatable and are therefore fatal within a few years. Unfortunately we know very little about how these leukemias develop and why they are so resistant to therapy. In addition, methods that produce mouse leukemias do not generate diseases that closely resemble human leukemias. Therefore models that would allow to study the initiation and progression of leukemia directly in human cells are needed. The objective of my project is to create and study such a model of a human leukemia by introducing a mutant gene into normal human cells and cells that are pre-leukemic. In my preliminary experiments, I have already discovered that this can work and the altered cells produce an aggressive human leukemia when they are transplanted into mice that lack an immune system. I now propose to investigate the molecular changes that cause this generation of a leukemia in the targeted cells. My results should create a foundation for the future development of definitive curative strategies and also broaden our understanding of the behaviour of other cancers where the same mutant gene is active.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bulaeva, Elizaveta
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~